Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
fda
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
amgen
biogen
cancer
deals
deerfield management
europe blog main
europe top stories
gilead sciences
ipo
What
medicines
4
×
fda
new
bio
covid
deal
drug
ipo
roundup
acquire
acquisitions
activity
agreed
amgen
announced
approval
approvals
billion
biogen
brings
candidates
cash
ceo
cholesterol
clamped
class
collabs
company
compound
daniel
delays
developed
developing
economic
fast
gets
gilead
gilead’s
head
help
Language
unset
Current search:
fda
×
biotech
×
medicines
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines